End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25 INR | 0.00% |
|
-1.96% | -17.22% |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 194.1 | 177.7 | 250.5 | 387.9 |
EBITDA 1 | 15.42 | 19.69 | 20.06 | 32.37 |
EBIT 1 | 14.25 | 18.2 | 18.76 | 31.36 |
Operating Margin | 7.34% | 10.24% | 7.49% | 8.08% |
Earnings before Tax (EBT) 1 | 15.77 | 18.16 | 25.11 | 42.18 |
Net income 1 | 11.55 | 12.54 | 19.54 | 34.32 |
Net margin | 5.95% | 7.05% | 7.8% | 8.85% |
EPS 2 | 0.8156 | 0.8851 | 1.380 | 2.423 |
Free Cash Flow | - | 17.25 | -2.518 | -30.87 |
FCF margin | - | 9.71% | -1.01% | -7.96% |
FCF Conversion (EBITDA) | - | 87.63% | - | - |
FCF Conversion (Net income) | - | 137.62% | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 25/01/23 | 25/01/23 | 25/01/23 | 21/07/23 |
Balance Sheet Analysis
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 2.13 | 25.9 | 27.6 | 33.8 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | 0.138 x | 1.315 x | 1.375 x | 1.044 x |
Free Cash Flow | - | 17.3 | -2.52 | -30.9 |
ROE (net income / shareholders' equity) | - | 8.53% | 12% | 18.1% |
ROA (Net income/ Total Assets) | - | 4.93% | 4.39% | 7.08% |
Assets 1 | - | 254.4 | 444.7 | 484.9 |
Book Value Per Share 2 | 9.940 | 10.80 | 12.20 | 14.60 |
Cash Flow per Share 2 | 0.1800 | 0.0700 | 0.0400 | 0.0600 |
Capex | - | 3.35 | 0 | 0.01 |
Capex / Sales | - | 1.89% | 0% | 0% |
Announcement Date | 25/01/23 | 25/01/23 | 25/01/23 | 21/07/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-17.22% | 5.77M | |
+20.77% | 68.72B | |
-4.97% | 46.48B | |
+24.89% | 44.63B | |
+32.42% | 28.07B | |
+8.74% | 19.25B | |
+15.57% | 17.26B | |
-12.49% | 15.12B | |
-29.11% | 14.16B | |
-31.12% | 12.22B |
- Stock Market
- Equities
- YCCL Stock
- Financials Yasons Chemex Care Limited